Product Description

Tagbef 250mg Tablet is a targeted therapy containing the active constituent gefitinib. It is used to treat non-small cell lung cancer (NSCLC). It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who had no previous cancer treatment. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung.

Tagbef 250mg Tablet is not recommended for adolescents and children under 18 years of age. Talk to your doctor if you have any other lung problems, liver disorders, or eye problems before taking this medicine. Use effective birth control during the treatment and for at least 2 weeks after the last dose. Talk to your doctor if you are taking medicines for ulcers or blood clots or if you have an intolerance to sugars.

How to use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tabgef 250mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Uses

Treatment of Lung cancer

Side Effects

Serious:

• Severe allergic reactions (swelling of lips, tongue, or throat, difficulty breathing, swallowing, rash)
• Dehydration

Common:

• Diarrhea
• Nausea, vomiting
• Loss of appetite
• Weakness
• Red or sore moth
• Itchy, dry, or cracked skin
• Dry, red, or itchy eyes
• Nail problems
• Hair loss
• Fever
• Nosebleed, blood in the urine
• Increased liver enzymes

Storage

Store below 30℃